Live stroke webinar during national awareness week

Stroke prevention, including current and potential treatments were among the topics discussed during the Perron Institute’s LIVE webinar on 2 September.

The event, aligned with National Stroke Week, was hosted by well known Perth media identity Tina Altieri. It provided an excellent opportunity for people to hear directly from one of Australia’s leading neurologists, Perron Institute Medical Director Clinical Professor David Blacker, who runs a stroke clinic at the Perron Institute and is also a neurologist at Sir Charles Gairdner Hospital.

The discussion drew an online audience from across Australia, as well as internationally, with guests tuning in from as far as India and Taiwan.

Questions from viewers ranged from seeking advice on current medications and treatments to potential treatments and the timing of their development.

One of these is a new drug named ARG-007 which has the potential to minimise brain damage when administered soon after stroke. Dr Blacker shared insights about the work being done by researchers at the Perron Institute to progress ARG -007 towards commercialisation. The treatment is currently undergoing preclinical studies, including a safety study supported by MSWA and Argenica Therapeutics, the company that has been set up to progress development of the drug.

Perron Institute’s LIVE webinar series will continue in 2021.

In partnership with the town of Cambridge, a community health seminar on stroke will be taking place at The Boulevard Centre at Floreat Forum on 13 October with Associate Professor Bruno Meloni and Dr Adam Edwards. They will be discussing their research involving ARG-007 and what it means both for adults and infants who could suffer stroke in the future.

Registrations are essential:

For more information on the health seminars, go to: